Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients.

Hendrich C, Franz E, Waertel G, Krebs R, Jäger M.

Orthop Rev (Pavia). 2009 Oct 10;1(2):e32. doi: 10.4081/or.2009.e32.

2.

Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects.

Jäger M, Herten M, Fochtmann U, Fischer J, Hernigou P, Zilkens C, Hendrich C, Krauspe R.

J Orthop Res. 2011 Feb;29(2):173-80. doi: 10.1002/jor.21230. Epub 2010 Aug 25.

3.

Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects.

Miller MA, Ivkovic A, Porter R, Harris MB, Estok DM 2nd, Smith RM, Evans CH, Vrahas MS.

Int Orthop. 2011 Apr;35(4):599-605. doi: 10.1007/s00264-010-1013-9. Epub 2010 Apr 23.

4.

Bone-marrow-derived mononuclear cells with a porous hydroxyapatite scaffold for the treatment of osteonecrosis of the femoral head: a preliminary study.

Yamasaki T, Yasunaga Y, Ishikawa M, Hamaki T, Ochi M.

J Bone Joint Surg Br. 2010 Mar;92(3):337-41. doi: 10.1302/0301-620X.92B3.22483.

PMID:
20190302
5.

Spinning around or stagnation - what do osteoblasts and chondroblasts really like?

Zilkens C, Lögters T, Bittersohl B, Krauspe R, Lensing-Höhn S, Jäger M.

Eur J Med Res. 2010 Jan 29;15(1):35-43.

6.

Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.

Turnovcova K, Ruzickova K, Vanecek V, Sykova E, Jendelova P.

Cytotherapy. 2009;11(7):874-85. doi: 10.3109/14653240903188947.

PMID:
19903100
7.

Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering.

Yoshimi R, Yamada Y, Ito K, Nakamura S, Abe A, Nagasaka T, Okabe K, Kohgo T, Baba S, Ueda M.

J Craniofac Surg. 2009 Sep;20(5):1523-30. doi: 10.1097/SCS.0b013e3181b09b7e.

PMID:
19816290
8.
9.

Repair of bone defect using bone marrow cells and demineralized bone matrix supplemented with polymeric materials.

Kurkalli BG, Gurevitch O, Sosnik A, Cohn D, Slavin S.

Curr Stem Cell Res Ther. 2010 Mar;5(1):49-56.

PMID:
19807659
10.

Mesenchymal stem cells for bone repair and metabolic bone diseases.

Undale AH, Westendorf JJ, Yaszemski MJ, Khosla S.

Mayo Clin Proc. 2009 Oct;84(10):893-902. doi: 10.1016/S0025-6196(11)60506-5. Review.

11.

Cell therapy of hip osteonecrosis with autologous bone marrow grafting.

Hernigou P, Poignard A, Zilber S, Rouard H.

Indian J Orthop. 2009 Jan;43(1):40-5. doi: 10.4103/0019-5413.45322.

12.

Differential effects of culture-expanded bone marrow cells on the regeneration of bone between the femoral and the tibial lengthenings.

Kitoh H, Kawasumi M, Kaneko H, Ishiguro N.

J Pediatr Orthop. 2009 Sep;29(6):643-9. doi: 10.1097/BPO.0b013e3181b2afb2.

PMID:
19700998
13.

Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion.

Granchi D, Ochoa G, Leonardi E, Devescovi V, Baglìo SR, Osaba L, Baldini N, Ciapetti G.

Tissue Eng Part C Methods. 2010 Jun;16(3):511-24. doi: 10.1089/ten.TEC.2009.0405.

PMID:
19686055
14.

Bone repair by transplantation of hTERT-immortalized human mesenchymal stem cells in mice.

Nakahara H, Misawa H, Hayashi T, Kondo E, Yuasa T, Kubota Y, Seita M, Kawamoto H, Hassan WA, Hassan RA, Javed SM, Tanaka M, Endo H, Noguchi H, Matsumoto S, Takata K, Tashiro Y, Nakaji S, Ozaki T, Kobayashi N.

Transplantation. 2009 Aug 15;88(3):346-53. doi: 10.1097/TP.0b013e3181ae5ba2.

PMID:
19667936
15.

The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.

Alsousou J, Thompson M, Hulley P, Noble A, Willett K.

J Bone Joint Surg Br. 2009 Aug;91(8):987-96. doi: 10.1302/0301-620X.91B8.22546. Review.

PMID:
19651823
16.

Runx2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation.

Hoeppner LH, Secreto F, Jensen ED, Li X, Kahler RA, Westendorf JJ.

J Cell Physiol. 2009 Nov;221(2):480-9. doi: 10.1002/jcp.21879.

17.

Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.

Coipeau P, Rosset P, Langonne A, Gaillard J, Delorme B, Rico A, Domenech J, Charbord P, Sensebe L.

Cytotherapy. 2009;11(5):584-94. doi: 10.1080/14653240903079385.

PMID:
19626496
18.

Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells.

Wang BL, Sun W, Shi ZC, Zhang NF, Yue DB, Guo WS, Xu SQ, Lou JN, Li ZR.

Arch Orthop Trauma Surg. 2010 Jul;130(7):859-65. doi: 10.1007/s00402-009-0939-0. Epub 2009 Jul 21.

PMID:
19621230
19.

Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP.

Yin D, Wang Z, Gao Q, Sundaresan R, Parrish C, Yang Q, Krebsbach PH, Lichtler AC, Rowe DW, Hock J, Liu P.

Mol Ther. 2009 Nov;17(11):1967-78. doi: 10.1038/mt.2009.151. Epub 2009 Jul 14.

20.

Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine.

Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, Sharma M, Sharma P, Tripathi RP, Gurudutta GU.

J Cell Mol Med. 2009 Nov-Dec;13(11-12):4385-402. doi: 10.1111/j.1582-4934.2009.00857.x. Epub 2009 Jul 10. Review.

Supplemental Content

Support Center